ETF · holdings as filed 2026-04-30

What's inside ARKG?

ARK Genomic Revolution ETF
Holdings
33
positions in the fund
Top 10
59%
of fund assets
Expense ratio
0.75%
net, per year
Fund size
$1B
total net assets
Sectors
Top holdings — Health Care
Your 10 largest positions in this sector
1
T
TWSTTWIST BIOSCIENCE CORP
9.02%
2
C
CRSPCRISPR THERAPEUTICS AG
8.94%
3
T
TXG10X GENOMICS INC-CLASS A
5.78%
4
B
BEAMBEAM THERAPEUTICS INC
5.44%
5
N
NTRANATERA INC
4.08%
6
I
ILMNILLUMINA INC
4.04%
7
N
NTLAINTELLIA THERAPEUTICS INC
3.83%
8
P
PSNLPERSONALIS INC
3.59%
9
R
RXRXRECURSION PHARMACEUTICALS-A
3.52%
10
G
GHGUARDANT HEALTH INC
3.51%
Geography
Top holdings — United States
Your 10 largest positions in this country
1
T
TEMTEMPUS AI INC-CL A
9.45%
2
T
TWSTTWIST BIOSCIENCE CORP
9.02%
3
T
TXG10X GENOMICS INC-CLASS A
5.78%
4
B
BEAMBEAM THERAPEUTICS INC
5.44%
5
A
ABSIABSCI CORP
4.79%
6
N
NTRANATERA INC
4.08%
7
I
ILMNILLUMINA INC
4.04%
8
N
NTLAINTELLIA THERAPEUTICS INC
3.83%
9
P
PSNLPERSONALIS INC
3.59%
10
R
RXRXRECURSION PHARMACEUTICALS-A
3.52%
Geography reflects each issuer's registered business address per SEC EDGAR filings where available, falling back to the exchange or listing where no SEC filing exists — not necessarily where a company's stock is primarily listed (e.g. TSMC is classified as Taiwan even though its ADR trades on the NYSE).
Hold ARKG alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.